Participatory Changemaking

Address Patent Thickets, Improve Competition, and Lower Prescription Drug Prices

The proposed policies set out in the blueprint are based on specifically addressing some of the root causes and strategies brand-name drugmakers use to build patent thickets under the current laws and procedures. It calls for sensible and long overdue reforms that will return integrity to the patent system by strengthening transparency, encouraging evidence-based policy, and raising the level of patent quality and inventiveness, all while strengthening competition and helping lower drug prices.